Skip to main content

Physiological Correlates of Premenstrual Dysphoric Disorder (PMDD)

  • Chapter
  • First Online:

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 21))

Abstract

Premenstrual dysphoric disorder (PMDD) is a mood disorder with onset of functionally impairing or distressing mood symptoms in the late luteal phase of the menstrual cycle. Psychophysiologic findings in PMDD broadly fall into two categories: vulnerability trait findings, thus categorized because they are present in the asymptomatic phases of the menstrual cycle, and state findings, which are only present in the symptomatic late luteal phase and which are potentially representative of the hormonal events and biological mechanisms that lead to PMDD. Trait vulnerability markers in PMDD include diminished cardiovascular stress responses, lower heart rate variability (reflecting increased vagal tone), and lower P300 amplitude, eventually suggesting that women with PMDD share a number of physiological correlates with related anxiety and mood disorders. State findings in PMDD include lower luteal phase prepulse inhibition and altered luteal phase emotion processing. Lower prepulse inhibition in the late luteal phase may be an important ovarian steroid-influenced indicative of altered serotonergic neurotransmission, of relevance for women with PMDD. Attempts to determine the neural correlates of emotion processing in the late luteal phase are thus far inconsistent, but promising.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Andreano JM, Cahill L (2010) Menstrual cycle modulation of medial temporal activity evoked by negative emotion. Neuroimage 53:1286–1293

    Google Scholar 

  • Andreen L, Bixo M, Nyberg S et al (2003) Progesterone effects during sequential hormone replacement therapy. Eur J Endocrinol 148:571–577

    Google Scholar 

  • Andreen L, Sundstrom-Poromaa I, Bixo M et al (2005) Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrino 30:212–224

    Google Scholar 

  • Andreen L, Sundstrom-Poromaa I, Bixo M et al (2006) Allopregnanolone concentration and mood–a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) 187:209–221

    Google Scholar 

  • Backstrom T, Andersson A, Andree L et al (2003) Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 1007:42–53

    Google Scholar 

  • Backstrom T, Bixo M, Johansson M et al (2014) Allopregnanolone and mood disorders. Prog Neurobiol 113:88–94

    Google Scholar 

  • Baker FC, Colrain IM (2010) Daytime sleepiness, psychomotor performance, waking EEG spectra and evoked potentials in women with severe premenstrual syndrome. J Sleep Res 19:214–227

    Google Scholar 

  • Baker FC, Colrain IM, Trinder J (2008) Reduced parasympathetic activity during sleep in the symptomatic phase of severe premenstrual syndrome. J Psychosom Res 65:13–22

    Google Scholar 

  • Baller EB, Wei SM, Kohn PD et al (2013) Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. Am J Psychiatry 170:305–14

    Google Scholar 

  • Bannbers E, Gingnell M, Engman J et al (2012) The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition. J Affect Disord 142:347–350

    Google Scholar 

  • Bannbers E, Kask K, Wikstrom J et al (2011) Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects. Psychoneuroendocrino 36:1184–1192

    Google Scholar 

  • Bixo M, Andersson A, Winblad B et al (1997) Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 764:173–178

    Google Scholar 

  • Bixo M, Backstrom T, Winblad B et al (1995) Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 55:297–303

    Google Scholar 

  • Bixo M, Backstrom T, Winblad B et al (1986) Comparison between pre- and postovulatory distributions of oestradiol and progesterone in the brain of the PMSG-treated rat. Acta Physiol Scand 128:241–246

    Google Scholar 

  • Borgstrom A, Kask K, Gulinello M et al (2008) Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrino 33:487–496

    Google Scholar 

  • Brinton RD, Thompson RF, Foy MR et al (2008) Progesterone receptors: form and function in brain. Front Neuroendocrinol 29:313–339

    Google Scholar 

  • Brown J, O’Brien PM, Marjoribanks J et al (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev CD001396

    Google Scholar 

  • Byrnes EM, Bridges RS, Scanlan VF et al (2007) Sensorimotor gating and dopamine function in postpartum rats. Neuropsychopharmacolog 32:1021–1031

    Google Scholar 

  • Cajochen C, Krauchi K, Wirz-Justice A (1997) The acute soporific action of daytime melatonin administration: effects on the EEG during wakefulness and subjective alertness. J Biol Rhythms 12:636–643

    Google Scholar 

  • Charitidi K, Meltser I, Canlon B (2012) Estradiol treatment and hormonal fluctuations during the estrous cycle modulate the expression of estrogen receptors in the auditory system and the prepulse inhibition of acoustic startle response. Endocrinology 153:4412–4421

    Google Scholar 

  • de Zambotti M, Nicholas CL, Colrain IM et al (2013) Autonomic regulation across phases of the menstrual cycle and sleep stages in women with premenstrual syndrome and healthy controls. Psychoneuroendocrinology 38:2618–2627

    Google Scholar 

  • Ehlers CL, Phillips E, Parry BL (1996) Electrophysiological findings during the menstrual cycle in women with and without late luteal phase dysphoric disorder: relationship to risk for alcoholism? Biol Psychiatry 39:720–732

    Google Scholar 

  • Epperson CN, Haga K, Mason GF et al (2002) Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59:851–858

    Google Scholar 

  • Epperson CN, Pittman B, Czarkowski KA et al (2007) Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology 32:2190–2198

    Google Scholar 

  • Etkin A, Wager TD (2007) Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164:1476–1488

    Google Scholar 

  • Freeman EW, Schweizer E, Rickels K (1995) Personality factors in women with premenstrual syndrome. Psychosom Med 57:453–459

    Google Scholar 

  • Gingnell M, Ahlstedt V, Bannbers E et al (2014) Social stimulation and corticolimbic reactivity in premenstrual dysphoric disorder: a preliminary study. Biol Mood Anxiety Disord 4:3

    Google Scholar 

  • Gingnell M, Bannbers E, Wikstrom J et al (2013) Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli. Eur Neuropsychopharmacol 23:1474–1483

    Google Scholar 

  • Gingnell M, Comasco E, Oreland L et al (2010) Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR. Arch Womens Ment Health 13:417-423

    Google Scholar 

  • Gingnell M, Morell A, Bannbers E et al (2012) Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder. Horm Behav 62:400–406

    Google Scholar 

  • Girdler SS, Leserman J, Bunevicius R et al (2007) Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder. Health Psychol 26:201–213

    Google Scholar 

  • Girdler SS, Pedersen CA, Stern RA et al (1993) Menstrual cycle and premenstrual syndrome: modifiers of cardiovascular reactivity in women. Health Psychol 12:180–192

    Google Scholar 

  • Girdler SS, Pedersen CA, Straneva PA et al (1998) Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. Psychiatry Res 81:163–178

    Google Scholar 

  • Girdler SS, Sherwood A, Hinderliter AL et al (2003) Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med 65:849–856

    Google Scholar 

  • Girdler SS, Straneva PA, Light KC et al (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788–797

    Google Scholar 

  • Gogos A, Kwek P, Chavez C et al (2010) Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors. J Pharmacol Exp Ther 333:218–227

    Google Scholar 

  • Gogos A, Kwek P, den Buuse M (2012) The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia. Psychopharmacology (Berl) 219:213–224

    Google Scholar 

  • Gogos A, Martin S, Jones ME et al (2006a) Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice. Psychopharmacology (Berl) 188:100–110

    Google Scholar 

  • Gogos A, Nathan PJ, Guille V et al (2006b) Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31:885–889

    Google Scholar 

  • Gogos A, Van den Buuse M (2004) Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309:267–274

    Google Scholar 

  • Gogos A, van den Buuse M, Rossell S (2009) Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. Int J Neuropsychopharmacol 12:1249–1259

    Google Scholar 

  • Goldstein JM, Jerram M, Abbs B et al (2010) Sex differences in stress response circuitry activation dependent on female hormonal cycle. J Neurosci 30:431–438

    Google Scholar 

  • Gruber CJ, Tschugguel W, Schneeberger C et al (2002) Production and actions of estrogens. N Engl J Med 346:340–352

    Google Scholar 

  • Grupe DW, Nitschke JB (2013) Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci 14:488–501

    Google Scholar 

  • Guerra-Araiza C, Cerbon MA, Morimoto S et al (2000) Progesterone receptor isoforms expression pattern in the rat brain during the estrous cycle. Life Sci 66:1743–1752

    Google Scholar 

  • Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I (2002) Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull 59:105–109

    Google Scholar 

  • Guerra-Araiza C, Villamar-Cruz O, Gonzalez-Arenas A et al (2003) Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J Neuroendocrinol 15:984–990

    Google Scholar 

  • Guille V, Gogos A, Nathan PJ et al (2011) Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity. J Psychopharmacol 25:1614–1622

    Google Scholar 

  • Gulinello M, Orman R, Smith SS (2003) Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 17:641–648

    Google Scholar 

  • Gulinello M, Smith SS (2003) Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats. J Pharmacol Exp Ther 305:541-548

    Google Scholar 

  • Hill RA, Wu YW, Gogos A et al (2013) Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones. J Neurochem 126:389–399

    Google Scholar 

  • Jovanovic H, Cerin A, Karlsson P et al (2006) A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 148:185–193

    Google Scholar 

  • Kask K, Backstrom T, Gulinello M et al (2008a) Lower levels of prepulse inhibition of startle response in pregnant women compared to postpartum women. Psychoneuroendocrinology 33:100–107

    Google Scholar 

  • Kask K, Backstrom T, Lundgren P et al (2009) Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls. Pharmacol Biochem Behav 92:608–613

    Google Scholar 

  • Kask K, Gulinello M, Backstrom T et al (2008b) Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 33:2283–2290

    Google Scholar 

  • Kato J, Hirata S, Nozawa A et al (1994) Gene expression of progesterone receptor isoforms in the rat brain. Horm Behav 28:454–463

    Google Scholar 

  • Kendler KS, Karkowski LM, Corey LA et al (1998) Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 155:1234–1240

    Google Scholar 

  • Kumari V (2011) Sex differences and hormonal influences in human sensorimotor gating: implications for schizophrenia. Curr Top Behav Neurosci 8:141–154

    Google Scholar 

  • Kumari V, Aasen I, Papadopoulos A et al (2008) A comparison of prepulse inhibition in pre- and postmenopausal women and age-matched men. Neuropsychopharmacology 33:2610–2618

    Google Scholar 

  • Kumari V, Konstantinou J, Papadopoulos A et al (2010) Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women. Neuropsychopharmacology 35:929–937

    Google Scholar 

  • Landen M, Erlandsson H, Bengtsson F et al (2009) Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability. Neuropsychopharmacology 34:585–592

    Google Scholar 

  • Landen M, Wennerblom B, Tygesen H et al (2004) Heart rate variability in premenstrual dysphoric disorder. Neuropsychopharmacology 29:733–740

    Google Scholar 

  • Lang PJ, Davis M (2006) Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog Brain Res 156:3–29

    Google Scholar 

  • Lang PJ, Davis M, Ohman A (2000) Fear and anxiety: animal models and human cognitive psychophysiology. J Affect Disord 61:137–159

    Google Scholar 

  • Marjoribanks J, Brown J, O’Brien PM et al (2013) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 6:CD001396

    Google Scholar 

  • Matsumoto T, Ushiroyama T, Kimura T et al (2007) Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder. Biopsychosoc Med 1:24

    Google Scholar 

  • Melcangi RC, Panzica G, Garcia-Segura LM (2011) Neuroactive steroids: focus on human brain. Neuroscience 191:1–5

    Google Scholar 

  • O’Brien PM, Backstrom T, Brown C et al (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 14:13–21

    Google Scholar 

  • Osterlund MK, Gustafsson JA, Keller E et al (2000a) Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab 85:3840–3846

    Google Scholar 

  • Osterlund MK, Keller E, Hurd YL (2000b) The human forebrain has discrete estrogen receptor alpha messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 95:333–342

    Google Scholar 

  • Ottander U, Poromaa IS, Bjurulf E et al (2005) Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol Cell Endocrinol 239:37–44

    Google Scholar 

  • Perkonigg A, Yonkers KA, Pfister H et al (2004) Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 65:1314–1322

    Google Scholar 

  • Pilver CE, Levy BR, Libby DJ et al (2011) Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder. Arch Womens Ment Health 14:383–93

    Google Scholar 

  • Protopopescu X, Tuescher O, Pan H et al (2008) Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 108:87–94

    Google Scholar 

  • Roberto M, Gilpin NW, Siggins GR (2012) The central amygdala and alcohol: role of gamma-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb Perspect Med 2:a012195

    Google Scholar 

  • Sadler C, Smith H, Hammond J et al (2010) Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton women’s survey. J Womens Health (Larchmt) 19:391–396

    Google Scholar 

  • Schmidt PJ, Nieman LK, Danaceau MA et al (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209–216

    Google Scholar 

  • Segebladh B, Bannbers E, Kask K et al (2011) Prevalence of violence exposure in women with premenstrual dysphoric disorder in comparison with other gynecological patients and asymptomatic controls. Acta Obstet Gynecol Scand 90:746–752

    Google Scholar 

  • Segebladh B, Borgstrom A, Nyberg S et al (2009) Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 201(139): e1–8

    Google Scholar 

  • Shin LM, Liberzon I (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35:169–191

    Google Scholar 

  • Sundstrom I, Backstrom T (1998) Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol Psychiatry 44:755–764

    Google Scholar 

  • Sundstrom Poromaa I, Smith S, Gulinello M (2003) GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 6:23–41

    Google Scholar 

  • Talledo JA, Sutherland Owens AN, Schortinghuis T et al (2009) Amphetamine effects on startle gating in normal women and female rats. Psychopharmacology (Berl) 204:165–175

    Google Scholar 

  • Thwaites SJ, van den Buuse MGogos A (2014) Differential effects of estrogen and testosterone on auditory sensory gating in rats. Psychopharmacology (Berl) 231:243–56

    Google Scholar 

  • Toufexis DJ, Davis C, Hammond A et al (2004) Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 24:10280–10287

    Google Scholar 

  • Toufexis DJ, Rochford J, Walker CD et al (1999) Lactation-induced reduction in rats’ acoustic startle is associated with changes in noradrenergic neurotransmission. Behav Neurosci 113:176–184

    Google Scholar 

  • Vaillancourt C, Cyr M, Rochford J et al (2002) Effects of ovariectomy and estradiol on acoustic startle responses in rats. Pharmacol Biochem Behav 74:103–109

    Google Scholar 

  • van den Akker O, Steptoe A (1989) Psychophysiological responses in women reporting severe premenstrual symptoms. Psychosom Med 51:319–328

    Google Scholar 

  • van den Buuse M, Eikelis N (2001) Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425:33–41

    Google Scholar 

  • van Wingen GA, van Broekhoven F, Verkes RJ et al (2008) Progesterone selectively increases amygdala reactivity in women. Mol Psychiatry 13:325–333

    Google Scholar 

  • Wang M, Seippel L, Purdy RH et al (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81:1076–1082

    Google Scholar 

  • Wittchen HU, Becker E, Lieb R et al (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119–132

    Google Scholar 

  • Wittchen HU, Perkonigg A, Pfister H (2003) Trauma and PTSD—an overlooked pathogenic pathway for premenstrual dysphoric disorder? Arch Women Ment Health 6:293–297

    Google Scholar 

  • Wu YC, Hill RA, Gogos A et al (2013) Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience 239:67–83

    Google Scholar 

  • Wyatt KM, Dimmock PW, Ismail KM et al (2004) The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG 111:585–593

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Inger Sundström Poromaa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Poromaa, I.S. (2014). Physiological Correlates of Premenstrual Dysphoric Disorder (PMDD). In: Kumari, V., Bob, P., Boutros, N. (eds) Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology. Current Topics in Behavioral Neurosciences, vol 21. Springer, Cham. https://doi.org/10.1007/7854_2014_296

Download citation

Publish with us

Policies and ethics